LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Sutton, AJ; Gay, NJ; Edmunds, WJ; Gill, ON (2008)
Publisher: Cambridge University Press (CUP)
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: mental disorders, virus diseases, social sciences, behavioral disciplines and activities, population characteristics
SUMMARYSince 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited periods, suggesting that short campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the flow of prisoners through prisons stratified by injecting status to compare a range of vaccination scenarios that describe vaccination on prison reception or via regular short campaigns. Model results suggest that vaccinating on prison reception can capture a greater proportion of the injecting drug user (IDU) population than the comparable campaign scenarios (63% vs. 55.6% respectively). Vaccination on prison reception is also more efficient at capturing IDUs for vaccination than vaccination via a campaign, although vaccination via campaigns may have a role with some infections for overall control.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and UASSG. Shooting up ; infections among injecting drug users in the United Kingdom 2004 : an update, October 2005. London : Health Protection Agency, 2005.
    • 2. Health Protection Agency (www.hpa.org.uk). Accessed December 2006.
    • 3. Weild AR, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales : a National Survey. Communicable Disease and Public Health 2000 ; 3 : 121-126.
    • 4. Sutton AJ, et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection 2006 ; 134 : 231-242.
    • 5. Gore SM, et al. Anonymous HIV surveillance with risk-factor elicitation : at Perth (for men) and Cornton Vale (for women) prisons in Scotland. International Journal of STD & AIDS 1997 ; 3 : 166-175.
    • 6. Allwright S, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners : results of a national cross sectional survey. British Medical Journal 2000 ; 321 : 78-82.
    • 7. Vong S, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis a outbreak among methamphetamine drug users. Vaccine 2005 ; 23 : 1021-1028.
    • 8. Gilbert RL, et al. Hepatitis A vaccination - a prisonbased solution for a community-based outbreak ? Communicable Disease and Public Health 2004 ; 7 : 289-293.
    • 9. Gilbert RL, et al. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Communicable Disease and Public Health 2004 ; 7 : 306-311.
    • 10. Hutchinson SJ, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004 ; 23 : 210-214.
    • 11. Sutton AJ, Gay NJ, Edmunds WJ. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine 2006 ; 24 : 2377-2386.
    • 12. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations : a review of epidemiology and prevention. AIDS 2005 ; 19 (Suppl. 3) : S41-S46.
    • 13. Bird AG, et al. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995 ; 9 : 801-808.
    • 14. Sutton AJ, et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infectious Diseases 2006 ; 6 : 93.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article